ArticleJournal of pharmacy & bioallied sciences2025
Global Epidemiology of Quid Usage and Occurrence of Potentially Malignant Disorders and Oral Cancer: A Cross-Sectional Study.
Article in Journal of pharmacy & bioallied sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Hardly any study has been reported in the literature related to the occurrence of potentially malignant disorders with respect to the usage of smokeless forms of quid. Aim: To assess the prevalence of potentially malignant disorders and clinical correlation with the consumption of smokeless forms of quid. Materials and Methods: The study was conducted among 1800 smokeless quid chewers. Detailed habit history of chewing tobacco, arecanut, and both tobacco and arecanut was taken. Identification of quid-induced potentially malignant disorders was done, which were recorded, namely, homogenous leukoplakia, Betel chewer's mucosa, quid-induced lichenoid reaction, Oral submucous fibrosis, Tobacco pouch keratosis, and Oral Cancer. Results: Prevalence of homogenous leukoplakia, betel chewer's mucosa, quid-induced lichenoid reaction, oral submucous fibrosis, tobacco pouch keratosis, and oral cancer was reported to be (14.1%), (2.5%), (1.2%), (28.4%), (26.5%), and (0.2%), respectively. 55% chewers had been using quid containing both tobacco and arecanut had been found to be more prone to the occurrence of potentially malignant disorders as compared to others chewing tobacco 25.8% and arecanut alone 19.2% and the difference was reported to be statistically significant. Conclusion: Further studies should be done to find out the actual composition of the type and forms of quid, along with its concentration, to analyze their role in the occurrence of quid-induced potentially malignant disorders.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.